Strengthening and expanding community-based approaches to delivering HIV treatment is vital to the long-term success of the AIDS response, according to a report launched on 20 April by Doctors Without Borders (MSF) and UNAIDS.
The report highlights MSF’s innovative approaches to the critical challenge of how to scale up treatment to ensure that people living with HIV have access to antiretroviral therapy through ways that fit in with their daily lives.
Taking place in London, on the occasion of the Board Meeting of the Partnership for Maternal and Child Health and of the Strategy and Coordination Group of Every Woman Every Child initiative, the launch was an opportunity to show that the meaningful involvement of the community in antiretroviral therapy delivery, adherence and retention initiatives works.
It was emphasised that the scale-up of financing and implementation of community-based service delivery will be essential to end the AIDS epidemic by 2030.
During the launch, Amina Mohammed, the Secretary-General’s Special Adviser on Post-2015 Development Planning, said, “I am glad that we have an opportunity to be reminded of the importance of ensuring that services and commodities reach the people and communities most in need.”
According to Tom Decroo, Operational Research Coordinator at MSF, “This document presents experiences of how community-based antiretroviral therapy delivery can improve both the level of access to HIV treatment and the quality of health outcomes for people living with HIV.
They are not one size fits all solutions, but they illustrate that community-based antiretroviral therapy delivery is efficient, effective and responds to the specific needs of people.”
Despite the progress made—there were 13.6 million people on treatment as of June 2014—there is still a long way to go. Only 38% of adults living with HIV and under a quarter of all children living with HIV have access to the life-saving medicines.
During the launch, Luiz Loures, UNAIDS Deputy Executive Director, noted that the move towards greater emphasis on community involvement could help better identify people in need of treatment, especially among the most marginalized and hard to reach populations.
He stressed that community-based antiretroviral therapy delivery is not only good for individuals, their families and their communities but has been shown to be more cost-effective, owing to better uptake, adherence and lower service provision cost.
Mr Loures also agreed that the pivotal role that civil society and communities have traditionally played in the AIDS response will need to be bolstered further.
“UNAIDS has launched a call for countries to Fast-Track towards ending the AIDS epidemic by 2030. If we are to reach this goal, we expect that by 2020 the percentage of community-based services will need to increase from 5% to 30%.
I am proud to promote documented efficient and effective innovations by MSF and many other organizations to achieve this goal.”
The publication presents a number of concrete models of relevant and appropriate community-based antiretroviral therapy delivery systems that are adapted to their particular contexts.
“By separating simple drug refills from the need for medical consultation (only necessary once a year for stable patients), those strategies adapt access to treatment to the realities experienced by people living with HIV.
They require adapting health service delivery to what makes it easier for patients to remain in lifelong, effective care, putting their needs at the heart of ART programmes”, says Dr Marc Biot, MSF’s operational coordinator for HIV projects.
Examples of community-based antiretroviral therapy programmes include: adherence clubs, where peer counsellors dispense medicines and complete basic medical checks; free community antiretroviral therapy distribution points closer to patients’ homes; self-formed community antiretroviral therapy groups, where members take turns to collect medicines from the clinic and distribute them to others living nearby; and appointment spacing and fast-track refills in which clinical consultations occur less often and medicines are obtained for a longer period.
Adapted to a variety of situations, most of these often unconventional strategies have demonstrated reduced burdens for patients and health systems.
They have resulted in more people staying on medication, lowered service provider costs and helped enable people living with HIV to live healthier and more productive lives.
Find out more about MSF